Pharma Technology Focus – Issue 75
Pharma Technology Focus is now available on all devices. Read it for free here. Researchers from the University of Toronto have…
breast cancer
-
-
FDA approves expanded indication for Novartis drug Kisqali
Novartis has obtained approval from the US Food and Drug Administration (FDA) for its Kisqali (ribociclib) to treat hormone-receptor positive,…
-
UK study finds triple therapy can prevent breast cancer relapse
A new study by The Institute of Cancer Research, London, has revealed that use of triple therapy, rather than single…
